Zobrazeno 1 - 10
of 3 458
pro vyhledávání: '"Sommers, C."'
Autor:
Schleiff M; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, United States., Chen J; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, United States., Yang J; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, United States., Sommers C; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, United States., Shen X; Office of Compounding Quality and Compliance, Office of Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, United States., Rodriguez J; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, United States., Keire D; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, United States., Shu Q; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, United States. Electronic address: Qin.Shu@fda.hhs.gov.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Oct 15; Vol. 249, pp. 116374. Date of Electronic Publication: 2024 Jul 20.
Within the Kubo-Greenwood formalism we use the fully relativistic, spin-polarized, screened Korringa-Kohn-Rostoker method together with the coherent-potential approximation for layered systems to calculate the resistivity for the permalloy series Ni$
Externí odkaz:
http://arxiv.org/abs/cond-mat/0007507
Autor:
Shu Q; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA. Electronic address: Qin.Shu@fda.hhs.gov., Schleiff M; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA., Sommers C; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA., Yang J; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA., Shen X; Office of Compounding Quality and Compliance, Office of Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA., Rodriguez JD; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA., Keire D; Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 May 15; Vol. 242, pp. 116010. Date of Electronic Publication: 2024 Feb 10.
Autor:
Abdullah AM; Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States., Sommers C; Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States., Rodriguez JD; Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States., Zhang D; Division of Therapeutic Performance I, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States., Kozak D; Division of Therapeutic Performance I, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States., Hawes J; Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079, United States., Sapru M; Division of New Drug Product III, Office of New Drug Product, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States., Yang K; Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States.
Publikováno v:
Analytical chemistry [Anal Chem] 2024 Jan 16; Vol. 96 (2), pp. 904-909. Date of Electronic Publication: 2023 Dec 29.
Autor:
Mans J; Division of Complex Drug Analysis, Office of Testing and Research, Center for Drug Evaluation and Research, US Food and Drug Administration, St Louis, Missouri 63110, United States., Oyugi M; Immediate Office, Office of Testing and Research, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 20993, United States., Asmelash B; Division of Complex Drug Analysis, Office of Testing and Research, Center for Drug Evaluation and Research, US Food and Drug Administration, St Louis, Missouri 63110, United States., Sommers C; Division of Complex Drug Analysis, Office of Testing and Research, Center for Drug Evaluation and Research, US Food and Drug Administration, St Louis, Missouri 63110, United States., Rogstad S; Immediate Office, Office of Testing and Research, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 20993, United States.
Publikováno v:
Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2023 Nov 01; Vol. 34 (11), pp. 2575-2584. Date of Electronic Publication: 2023 Oct 16.
Autor:
Yang J; Office of Testing and Research, Center of Drug Evaluation and Research, US Food and Drug Administration, Saint Louis, MO 63110, USA., Kakarla R; Office of Testing and Research, Center of Drug Evaluation and Research, US Food and Drug Administration, Saint Louis, MO 63110, USA., Marzan T; Office of Testing and Research, Center of Drug Evaluation and Research, US Food and Drug Administration, Saint Louis, MO 63110, USA., Sherwin B; TGA Laboratories, 136 Narrabundah Lane, Symonston, Canberra, A.C.T 2606, Australia., George M; TGA Laboratories, 136 Narrabundah Lane, Symonston, Canberra, A.C.T 2606, Australia., Bennett J; TGA Laboratories, 136 Narrabundah Lane, Symonston, Canberra, A.C.T 2606, Australia., Basutto J; TGA Laboratories, 136 Narrabundah Lane, Symonston, Canberra, A.C.T 2606, Australia., Su Y; Health Products Laboratory Program, Regulatory Operations and Enforcement Branch, Department of Health, Government of Canada, 2301 Midland Ave, Toronto ON, M1P 4R7, Canada., Ollerenshaw J; Health Products Laboratory Program, Regulatory Operations and Enforcement Branch, Department of Health, Government of Canada, 2301 Midland Ave, Toronto ON, M1P 4R7, Canada., Morin J; Health Products Laboratory Program, Regulatory Operations and Enforcement Branch, Department of Health, Government of Canada, 2301 Midland Ave, Toronto ON, M1P 4R7, Canada., Rebière H; French National Agency for the Safety of Medicines and Health Products (ANSM), Laboratory Controls Division; 635 Rue de la Garenne, 34740 Vendargues, France., Maggio AF; French National Agency for the Safety of Medicines and Health Products (ANSM), Laboratory Controls Division; 635 Rue de la Garenne, 34740 Vendargues, France., Kermaïdic A; French National Agency for the Safety of Medicines and Health Products (ANSM), Laboratory Controls Division; 635 Rue de la Garenne, 34740 Vendargues, France., Gervela E; French National Agency for the Safety of Medicines and Health Products (ANSM), Laboratory Controls Division; 635 Rue de la Garenne, 34740 Vendargues, France., Brenier C; French National Agency for the Safety of Medicines and Health Products (ANSM), Laboratory Controls Division; 635 Rue de la Garenne, 34740 Vendargues, France., Civade C; French National Agency for the Safety of Medicines and Health Products (ANSM), Laboratory Controls Division; 635 Rue de la Garenne, 34740 Vendargues, France., Chauvey D; French National Agency for the Safety of Medicines and Health Products (ANSM), Laboratory Controls Division; 635 Rue de la Garenne, 34740 Vendargues, France., Duperray F; French National Agency for the Safety of Medicines and Health Products (ANSM), Laboratory Controls Division; 635 Rue de la Garenne, 34740 Vendargues, France., Wollein U; Department of Pharmacy (OMCL), Bavarian Health and Food Safety Authority, Veterinaerstr. 2 85764 Oberschleissheim, Germany., Conti M; Schweizerisches Heilmittelinstitut (Biol. & Pharm.), OMCL Swissmedic, Hallerstrasse 7, 3012, Bern, Switzerland., Tromp J; Schweizerisches Heilmittelinstitut (Biol. & Pharm.), OMCL Swissmedic, Hallerstrasse 7, 3012, Bern, Switzerland., Meyer S; Schweizerisches Heilmittelinstitut (Biol. & Pharm.), OMCL Swissmedic, Hallerstrasse 7, 3012, Bern, Switzerland., Wanko R; Biological Standardisation, OMCL Network & HealthCare Department (DBO), EDQM - Council of Europe - Conseil de l'Europe, 7 Allée Kastner CS 30026 F- 67081 Strasbourg, France., Wierer M; Biological Standardisation, OMCL Network & HealthCare Department (DBO), EDQM - Council of Europe - Conseil de l'Europe, 7 Allée Kastner CS 30026 F- 67081 Strasbourg, France., Bertrand M; Biological Standardisation, OMCL Network & HealthCare Department (DBO), EDQM - Council of Europe - Conseil de l'Europe, 7 Allée Kastner CS 30026 F- 67081 Strasbourg, France., Rodriguez J; Office of Testing and Research, Center of Drug Evaluation and Research, US Food and Drug Administration, Saint Louis, MO 63110, USA., Sommers C; Office of Testing and Research, Center of Drug Evaluation and Research, US Food and Drug Administration, Saint Louis, MO 63110, USA., Keire D; Office of Testing and Research, Center of Drug Evaluation and Research, US Food and Drug Administration, Saint Louis, MO 63110, USA. Electronic address: david.keire@fda.hhs.gov.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2023 Oct; Vol. 112 (10), pp. 2685-2695. Date of Electronic Publication: 2023 Jul 29.
Autor:
Shipman J; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, MO, 63110, USA., Sommers C; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, MO, 63110, USA., Keire DA; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, MO, 63110, USA., Chen K; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, MO, 63110, USA. Kang.Chen@fda.hhs.gov., Zhu H; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, MO, 63110, USA. Hongbin.Zhu@fda.hhs.gov.
Publikováno v:
Pharmaceutical research [Pharm Res] 2023 Jun; Vol. 40 (6), pp. 1399-1410. Date of Electronic Publication: 2022 Dec 13.
Publikováno v:
Philosophical Magazine B. Nov98, Vol. 78 Issue 5/6, p591-595. 5p. 7 Graphs.
Autor:
Schleiff M; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA., Sommers C; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA., Yang J; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA., Shen X; Office of Compounding Quality and Compliance, Office of Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA., Rodriguez JD; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA., Shu Q; Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, St. Louis, MO 63110, USA. Electronic address: Qin.Shu@fda.hhs.gov.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2023 Jan 05; Vol. 222, pp. 115073. Date of Electronic Publication: 2022 Sep 22.